Use of derivatives of succinate esters for the treatment of dementia
    1.
    发明授权
    Use of derivatives of succinate esters for the treatment of dementia 有权
    使用琥珀酸酯衍生物治疗痴呆症

    公开(公告)号:US07557089B2

    公开(公告)日:2009-07-07

    申请号:US10541082

    申请日:2003-12-31

    摘要: The use of extract form Wangla (coeloglossum viride (L) Hartm. Var. Bracteatum (Willd.) Richter), succinate derivative esters, and a derivative and pharmaceutical acceptable salts thereof, for the manufacture of a pharmaceutical preparation for the treatment of dementia, particularly for the treatment of Alzheimer' disease and Vascular dementia. Through Animal experiment, it has been demonstrated that, succinate derivative esters can improve learning and memory ability in dementia rats induced by scopolamine and cyclohexenyl imine; improve learning and memory ability in dementia rats induced by β-amyloid; improve learning and memory ability in dementia rats induced by permanent ligation of bilateral carotid; and improve memory ability of normal animals. It has the advantage of high activity, low toxicity and no inhibition to cholinesterase.

    摘要翻译: 使用提取物形式用于制备用于治疗痴呆症的药物制剂的王of提取物(枸杞子(L)Hartm .V.B.Barleumum(Willd。)Richter),琥珀酸酯衍生物酯及其衍生物和药学上可接受的盐, 特别是用于治疗阿尔茨海默病和血管性痴呆。 通过动物实验,已经证明,琥珀酸衍生物酯可以改善由东莨菪碱和环己烯基亚胺诱导的痴呆大鼠的学习和记忆能力; 提高由β-淀粉样蛋白诱导的痴呆大鼠的学习和记忆能力; 提高双侧颈动脉永久性结扎引起的痴呆大鼠的学习记忆能力; 并提高正常动物的记忆能力。 具有活性高,毒性低,对胆碱酯酶无抑制作用。